2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | |
---|---|---|---|---|---|---|---|---|---|---|
Sales - EUR | - | - | 1.888 | 5.628 | 7.759 | 9.284 | 6.377 | 8.319 | 7.775 | 2.294 |
Total Income - EUR | - | - | 1.888 | 5.628 | 7.759 | 9.284 | 6.377 | 8.319 | 7.775 | 2.294 |
Total Expenses - EUR | - | - | 109 | 125 | 208 | 364 | 722 | 362 | 403 | 228 |
Gross Profit/Loss - EUR | - | - | 1.779 | 5.503 | 7.551 | 8.920 | 5.655 | 7.956 | 7.372 | 2.066 |
Net Profit/Loss - EUR | - | - | 1.722 | 5.334 | 7.318 | 8.641 | 5.473 | 7.707 | 7.139 | 1.735 |
Employees | - | - | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Check the financial reports for the company - Medicol Rx 26 Srl
See the company's note based on the submitted financial data, relative to the industry of which it is a part.
Check Financial Rating2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | |
---|---|---|---|---|---|---|---|---|---|---|
Fixed Assets | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | - | - |
Current Assets | - | - | 1.820 | 5.553 | 7.712 | 11.110 | 11.248 | 13.243 | 7.704 | 4.140 |
Inventories | - | - | 18 | 17 | 17 | 0 | 0 | 0 | 0 | 0 |
Receivables | - | - | 0 | 0 | 0 | 0 | 0 | 0 | 5.742 | 11 |
Cash | - | - | 1.802 | 5.536 | 7.695 | 11.110 | 11.248 | 13.243 | 1.962 | 4.128 |
Shareholders Funds | - | - | 1.767 | 5.378 | 7.547 | 10.879 | 10.977 | 12.983 | 7.387 | 3.844 |
Social Capital | - | - | 45 | 44 | 43 | 42 | 41 | 40 | 41 | 40 |
Debts | - | - | 53 | 176 | 165 | 231 | 271 | 260 | 317 | 296 |
Income in Advance | - | - | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Exchange rate - RON | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 | 4.4821 |
Main CAEN | "8622 - 8622" | |||||||||
CAEN Financial Year | 8622 |
Subscriptions Financial Reports
You can check the financial situation of the companies in relation to the industry of which it is a part, credit limits and the risk of insolvency and suspension of accounts.
Reports that can be accessed based on the subscription:
Get the contact details for any company and get in touch with it.